
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $4B | $4.6B | $4.5B | $4.1B | |
Revenue Growth (YoY) | 2.53% | 14.49% | 14.26% | -2.85% | -7.88% | |
Cost of Revenues | $2.6B | $2.9B | $3.2B | $3.2B | $2.9B | |
Gross Profit | $947.2M | $1.1B | $1.4B | $1.3B | $1.2B | |
Gross Profit Margin | 27.05% | 28.49% | 29.9% | 28.76% | 28.87% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $615M | $735.8M | $895M | $844.2M | $821.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $666M | $791.5M | $960.1M | $915.9M | $879.3M | |
Operating Income | $281.2M | $350.9M | $409.5M | $364.1M | $304.4M | |
Net Interest Expenses | $39.7M | $37.5M | $45.9M | $66.4M | $64.3M | |
EBT. Incl. Unusual Items | $241.5M | $313.4M | $363.6M | $297.7M | $240.1M | |
Earnings of Discontinued Ops. | $22.7M | $178.1M | $1.2M | -- | -- | |
Income Tax Expense | $63.9M | $81.6M | $96.7M | $78.4M | $64.9M | |
Net Income to Company | $200.3M | $409.9M | $268.1M | $219.3M | $175.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $200.3M | $409.9M | $268.1M | $219.3M | $175.2M | |
Basic EPS (Cont. Ops) | $3.80 | $7.78 | $5.30 | $4.54 | $3.88 | |
Diluted EPS (Cont. Ops) | $3.76 | $7.66 | $5.23 | $4.50 | $3.83 | |
Weighted Average Basic Share | $52.7M | $52.7M | $50.6M | $48.3M | $45.2M | |
Weighted Average Diluted Share | $53.3M | $53.5M | $51.3M | $48.7M | $45.7M | |
EBITDA | $370.9M | $440.5M | $500.9M | $464.4M | $400.7M | |
EBIT | $281.2M | $350.9M | $409.5M | $364.1M | $304.4M | |
Revenue (Reported) | $3.5B | $4B | $4.6B | $4.5B | $4.1B | |
Operating Income (Reported) | $281.2M | $350.9M | $409.5M | $364.1M | $304.4M | |
Operating Income (Adjusted) | $281.2M | $350.9M | $409.5M | $364.1M | $304.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $907M | $1.1B | $1.1B | $1B | $968.3M | |
Revenue Growth (YoY) | -8.43% | 20.29% | 3.47% | -7.07% | -7.69% | |
Cost of Revenues | $663.3M | $764.4M | $802.4M | $752.8M | $692.9M | |
Gross Profit | $243.7M | $326.6M | $326.4M | $296.2M | $275.4M | |
Gross Profit Margin | 26.87% | 29.94% | 28.92% | 28.24% | 28.44% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $164.3M | $212.1M | $224.1M | $210.2M | $214.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $176.3M | $226M | $242.2M | $225.3M | $228.8M | |
Operating Income | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Net Interest Expenses | $9.2M | $9.3M | $15.4M | $17.6M | $15.4M | |
EBT. Incl. Unusual Items | $58.2M | $91.3M | $68.8M | $53.3M | $31.2M | |
Earnings of Discontinued Ops. | $5.9M | -$800K | -- | -- | -- | |
Income Tax Expense | $15.4M | $23.7M | $19.3M | $15.2M | $10.3M | |
Net Income to Company | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Basic EPS (Cont. Ops) | $0.92 | $1.30 | $1.00 | $0.82 | $0.48 | |
Diluted EPS (Cont. Ops) | $0.91 | $1.28 | $0.99 | $0.81 | $0.48 | |
Weighted Average Basic Share | $53M | $51.6M | $49.3M | $46.5M | $43.7M | |
Weighted Average Diluted Share | $53.7M | $52.3M | $49.8M | $46.9M | $44M | |
EBITDA | $89.4M | $120.7M | $109.1M | $95.4M | $72.2M | |
EBIT | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Revenue (Reported) | $907M | $1.1B | $1.1B | $1B | $968.3M | |
Operating Income (Reported) | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Operating Income (Adjusted) | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $4.2B | $4.6B | $4.4B | $4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.6B | $3B | $3.2B | $3.1B | $2.9B | |
Gross Profit | $948.3M | $1.2B | $1.4B | $1.2B | $1.2B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $613.4M | $783.6M | $907M | $830.3M | $825.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $664.4M | $841.2M | $976.3M | $899M | $882.8M | |
Operating Income | $283.9M | $384.1M | $393.1M | $350.8M | $280.1M | |
Net Interest Expenses | $37.5M | $37.6M | $52M | $68.6M | $62.1M | |
EBT. Incl. Unusual Items | $246.4M | $346.5M | $341.1M | $282.2M | $218M | |
Earnings of Discontinued Ops. | $23.9M | $171.4M | $2M | -- | -- | |
Income Tax Expense | $65.1M | $89.9M | $92.3M | $74.3M | $60M | |
Net Income to Company | $205.2M | $428M | $250.8M | $207.9M | $158M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $205.2M | $428M | $250.8M | $207.9M | $158M | |
Basic EPS (Cont. Ops) | $3.90 | $8.16 | $5.00 | $4.35 | $3.54 | |
Diluted EPS (Cont. Ops) | $3.86 | $8.05 | $4.94 | $4.32 | $3.51 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $374.2M | $471.8M | $489.3M | $450.7M | $377.5M | |
EBIT | $283.9M | $384.1M | $393.1M | $350.8M | $280.1M | |
Revenue (Reported) | $3.5B | $4.2B | $4.6B | $4.4B | $4B | |
Operating Income (Reported) | $283.9M | $384.1M | $393.1M | $350.8M | $280.1M | |
Operating Income (Adjusted) | $283.9M | $384.1M | $393.1M | $350.8M | $280.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $907M | $1.1B | $1.1B | $1B | $968.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $663.3M | $764.4M | $802.4M | $752.8M | $692.9M | |
Gross Profit | $243.7M | $326.6M | $326.4M | $296.2M | $275.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $164.3M | $212.1M | $224.1M | $210.2M | $214.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $176.3M | $226M | $242.2M | $225.3M | $228.8M | |
Operating Income | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Net Interest Expenses | $9.2M | $9.3M | $15.4M | $17.6M | $15.4M | |
EBT. Incl. Unusual Items | $58.2M | $91.3M | $68.8M | $53.3M | $31.2M | |
Earnings of Discontinued Ops. | $5.9M | -$800K | -- | -- | -- | |
Income Tax Expense | $15.4M | $23.7M | $19.3M | $15.2M | $10.3M | |
Net Income to Company | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Basic EPS (Cont. Ops) | $0.92 | $1.30 | $1.00 | $0.82 | $0.48 | |
Diluted EPS (Cont. Ops) | $0.91 | $1.28 | $0.99 | $0.81 | $0.48 | |
Weighted Average Basic Share | $53M | $51.6M | $49.3M | $46.5M | $43.7M | |
Weighted Average Diluted Share | $53.7M | $52.3M | $49.8M | $46.9M | $44M | |
EBITDA | $89.4M | $120.7M | $109.1M | $95.4M | $72.2M | |
EBIT | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Revenue (Reported) | $907M | $1.1B | $1.1B | $1B | $968.3M | |
Operating Income (Reported) | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M | |
Operating Income (Adjusted) | $67.4M | $100.6M | $84.2M | $70.9M | $46.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $274.4M | $529.6M | $70.3M | $175.9M | $205.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $602.8M | $708.2M | $853.6M | $741.5M | $650.8M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $17.3M | $30.4M | $17.3M | $19.1M | $17.1M | |
Total Current Assets | $994.4M | $1.3B | $981.1M | $973.3M | $917.7M | |
Property Plant And Equipment | $127.9M | $112.1M | $117.4M | $145.6M | $144.5M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.4B | $1.6B | $1.9B | $1.9B | $1.9B | |
Other Intangibles | $469.9M | $487.9M | $569.6M | $497.9M | $439.8M | |
Other Long-Term Assets | $265.1M | $23.9M | $25.6M | $33.7M | $33.9M | |
Total Assets | $3.3B | $3.5B | $3.6B | $3.5B | $3.4B | |
Accounts Payable | $38.3M | $20.1M | $35.2M | $34M | $27.2M | |
Accrued Expenses | $238.5M | $305.5M | $285.1M | $236.5M | $218M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $24.3M | $23.3M | $22.9M | $19.5M | $19.5M | |
Other Current Liabilities | $115.1M | $102M | $98.7M | $104.1M | $102.4M | |
Total Current Liabilities | $416.2M | $450.9M | $441.9M | $394.1M | $367.1M | |
Long-Term Debt | $1B | $1B | $1.1B | $1B | $1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $1.6B | $1.7B | $1.7B | $1.7B | |
Common Stock | $500K | $500K | $500K | $500K | $400K | |
Other Common Equity Adj | -$1M | -$300K | -$2.7M | -- | -$5M | |
Common Equity | $1.6B | $1.9B | $1.9B | $1.9B | $1.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.6B | $1.9B | $1.9B | $1.9B | $1.8B | |
Total Liabilities and Equity | $3.3B | $3.5B | $3.6B | $3.5B | $3.4B | |
Cash and Short Terms | $274.4M | $529.6M | $70.3M | $175.9M | $205.2M | |
Total Debt | $1B | $1B | $1.1B | $1B | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $386.5M | $502.4M | $65M | $158.4M | $107M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $646.9M | $775.8M | $822.8M | $725.3M | $705.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $20.6M | $16.4M | $15.5M | $19.1M | $17.5M | |
Total Current Assets | $1.1B | $1.3B | $926.8M | $933.4M | $879.6M | |
Property Plant And Equipment | $144.5M | $112.3M | $124.3M | $146.2M | $140M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.6B | $1.6B | $1.9B | $1.9B | $2.1B | |
Other Intangibles | $475.6M | $474M | $551.5M | $482.8M | $504.4M | |
Other Long-Term Assets | $22.7M | $22.9M | $29.2M | $32.3M | $34.9M | |
Total Assets | $3.3B | $3.5B | $3.5B | $3.5B | $3.7B | |
Accounts Payable | $29.9M | $21.4M | $34M | $25.9M | $24.3M | |
Accrued Expenses | $284.7M | $312.2M | $251.6M | $232.7M | $211.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $28M | $23M | $21.1M | $20.5M | $19.8M | |
Other Current Liabilities | $86.3M | $82.5M | $79.2M | $92.6M | $79.7M | |
Total Current Liabilities | $428.9M | $439.1M | $385.9M | $371.7M | $371.5M | |
Long-Term Debt | $1B | $1B | $1B | $1B | $1.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $1.6B | $1.6B | $1.6B | $1.9B | |
Common Stock | $500K | $500K | $500K | $500K | $400K | |
Other Common Equity Adj | -$4.2M | -$300K | -$1.7M | -$200K | -$4.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.6B | $1.9B | $1.9B | $1.9B | $1.8B | |
Total Liabilities and Equity | $3.3B | $3.5B | $3.5B | $3.5B | $3.7B | |
Cash and Short Terms | $386.5M | $502.4M | $65M | $158.4M | $107M | |
Total Debt | $1B | $1B | $1B | $1B | $1.3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $200.3M | $409.9M | $268.1M | $219.3M | $175.2M | |
Depreciation & Amoritzation | $89.7M | $89.6M | $91.4M | $100.3M | $96.3M | |
Stock-Based Compensation | $32.3M | $52.7M | $49.3M | $44M | $42.3M | |
Change in Accounts Receivable | -$12.9M | -$111.1M | -$116.3M | $111M | $87M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $424.8M | $193.7M | $307.8M | $456.9M | $400M | |
Capital Expenditures | $32.6M | $34.7M | $37.5M | $39.9M | $35.3M | |
Cash Acquisitions | -$186.2M | $281M | -$474.8M | -- | -- | |
Cash From Investing | -$219M | $246.5M | -$510M | -$40.5M | -$35.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $65.5M | -- | $94M | $571.8M | -- | |
Long-Term Debt Repaid | -$65.5M | -- | -$62.5M | -$596.6M | -$5M | |
Repurchase of Common Stock | -$27.9M | -$181.3M | -$281.4M | -$273.1M | -$327.2M | |
Other Financing Activities | -$13.2M | -$17.4M | -$25.5M | -$31.9M | -$18.2M | |
Cash From Financing | -$29M | -$184.4M | -$256.5M | -$310.9M | -$333.2M | |
Beginning Cash (CF) | $95.2M | $274.4M | $529.6M | $70.3M | $175.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $176.8M | $255.8M | -$458.7M | $105.5M | $31.5M | |
Ending Cash (CF) | $274.4M | $529.6M | $70.3M | $175.9M | $205.2M | |
Levered Free Cash Flow | $392.2M | $159M | $270.3M | $417M | $364.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Depreciation & Amoritzation | $22M | $20.1M | $24.9M | $24.5M | $25.6M | |
Stock-Based Compensation | $10.3M | $12.8M | $12.1M | $11.7M | $13.8M | |
Change in Accounts Receivable | $30.3M | -$67.7M | $31M | $15.2M | -$31.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $119.8M | $56M | $80.5M | $73.3M | $16.8M | |
Capital Expenditures | $9.3M | $9.6M | $11.7M | $10.8M | $10.2M | |
Cash Acquisitions | -- | $9.8M | -- | -- | -$306.1M | |
Cash From Investing | -$9.4M | $200K | -$12.3M | -$10.8M | -$316.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $36M | -- | $265M | |
Long-Term Debt Repaid | -- | -- | -$67.5M | -$1.3M | -$16.3M | |
Repurchase of Common Stock | -- | -$76.9M | -$48.8M | -$79.7M | -$50.4M | |
Other Financing Activities | -$4.8M | -$16.9M | -$4.2M | -$8.5M | -$5.8M | |
Cash From Financing | $2.9M | -$83.4M | -$73.4M | -$80M | $201.2M | |
Beginning Cash (CF) | $274.4M | $529.6M | $70.3M | $175.9M | $205.2M | |
Foreign Exchange Rate Adjustment | -$1.2M | -- | -$100K | -- | $100K | |
Additions / Reductions | $113.3M | -$27.2M | -$5.2M | -$17.5M | -$98.3M | |
Ending Cash (CF) | $386.5M | $502.4M | $65M | $158.4M | $107M | |
Levered Free Cash Flow | $110.5M | $46.4M | $68.8M | $62.5M | $6.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $205.2M | $428M | $250.8M | $207.9M | $158M | |
Depreciation & Amoritzation | $90.3M | $87.7M | $96.2M | $99.9M | $97.4M | |
Stock-Based Compensation | $33.9M | $55.2M | $48.6M | $43.6M | $44.4M | |
Change in Accounts Receivable | $47.9M | -$209.1M | -$17.6M | $95.2M | $40.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $480.5M | $129.9M | $332.3M | $449.7M | $343.5M | |
Capital Expenditures | $26.6M | $35M | $39.6M | $39M | $34.7M | |
Cash Acquisitions | -$100.7M | $290.8M | -$484.6M | -- | -$306.1M | |
Cash From Investing | -$127.4M | $256.1M | -$522.5M | -$39M | -$340.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $130M | $535.8M | $265M | |
Long-Term Debt Repaid | -- | -- | -$130M | -$530.4M | -$20M | |
Repurchase of Common Stock | -- | -$258.2M | -$253.3M | -$304M | -$297.9M | |
Other Financing Activities | -$13.1M | -$29.5M | -$12.8M | -$36.2M | -$15.5M | |
Cash From Financing | -$32.2M | -$270.7M | -$246.5M | -$317.5M | -$52M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $320.9M | $115.3M | -$436.7M | $93.2M | -$49.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $453.9M | $94.9M | $292.7M | $410.7M | $308.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $48.7M | $66.8M | $49.5M | $38.1M | $20.9M | |
Depreciation & Amoritzation | $22M | $20.1M | $24.9M | $24.5M | $25.6M | |
Stock-Based Compensation | $10.3M | $12.8M | $12.1M | $11.7M | $13.8M | |
Change in Accounts Receivable | $30.3M | -$67.7M | $31M | $15.2M | -$31.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $119.8M | $56M | $80.5M | $73.3M | $16.8M | |
Capital Expenditures | $9.3M | $9.6M | $11.7M | $10.8M | $10.2M | |
Cash Acquisitions | -- | $9.8M | -- | -- | -$306.1M | |
Cash From Investing | -$9.4M | $200K | -$12.3M | -$10.8M | -$316.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $36M | -- | $265M | |
Long-Term Debt Repaid | -- | -- | -$67.5M | -$1.3M | -$16.3M | |
Repurchase of Common Stock | -- | -$76.9M | -$48.8M | -$79.7M | -$50.4M | |
Other Financing Activities | -$4.8M | -$16.9M | -$4.2M | -$8.5M | -$5.8M | |
Cash From Financing | $2.9M | -$83.4M | -$73.4M | -$80M | $201.2M | |
Beginning Cash (CF) | $274.4M | $529.6M | $70.3M | $175.9M | $205.2M | |
Foreign Exchange Rate Adjustment | -$1.2M | -- | -$100K | -- | $100K | |
Additions / Reductions | $113.3M | -$27.2M | -$5.2M | -$17.5M | -$98.3M | |
Ending Cash (CF) | $386.5M | $502.4M | $65M | $158.4M | $107M | |
Levered Free Cash Flow | $110.5M | $46.4M | $68.8M | $62.5M | $6.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.